McDonald's Corporation filings document the reporting framework for a global foodservice retailer built around franchised and company-operated restaurants. Form 8-K filings record quarterly and annual results releases, supplemental financial information, comparable sales, systemwide sales, loyalty activity, restructuring charges, and segment performance across U.S. and international markets.
The filing record also covers governance and capital-structure matters, including the definitive proxy statement, director elections, board committee assignments, executive and director compensation disclosures, and shareholder voting materials. Other event filings document medium-term note issuances under the company’s shelf registration program and related legal opinions, reflecting McDonald's use of public debt markets alongside its common stock structure.
McDonald’s Corp. (MCD) – Form 4 insider transaction
Joseph M. Erlinger, President of McDonald’s USA, reported the sale of 939 common shares on 07/23/2025 at $299.49 per share, for proceeds of roughly $281 k. After the sale he directly owns 9,283.12 shares; no indirect or derivative transactions were disclosed.
The disposal equals about 10 % of his reported stake but is immaterial versus McDonald’s ~742 million shares outstanding, so market impact is expected to be limited. No other changes in beneficial ownership were noted.
McDonald’s Corporation (MCD) Form 4 filing dated 06/23/2025 reveals a routine insider transaction. Joseph M. Erlinger, President of McDonald’s USA, sold 939 common shares at $288.52 per share, generating roughly $271,000 in proceeds.
After the sale, Erlinger still directly owns 10,222.12 shares. No derivative security activity, 10b5-1 plan indication, or additional commentary was disclosed. Given McDonald’s ~730 million shares outstanding, the transaction represents less than 0.0002% of shares and is unlikely to be financially material to investors.
McDonald's Form 144 filing details proposed sale of securities by insider Joseph Erlinger. The filing indicates a planned sale of 939 shares of common stock with an aggregate market value of $269,924.94 through Morgan Stanley Smith Barney LLC on the NYSE, scheduled for June 23, 2025.
The shares were originally acquired on March 8, 2020, as Performance Restricted Stock Units from the issuer. The filing also discloses previous 10b5-1 plan sales by Erlinger over the past three months:
- May 23, 2025: 939 shares sold for $295,850.73
- April 23, 2025: 939 shares sold for $299,071.50
- March 24, 2025: 939 shares sold for $287,615.70
Total outstanding shares reported: 715,032,727. This planned transaction appears to be part of a systematic selling program under Rule 10b5-1, with consistent monthly sales of the same share amount.